{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:36:53Z","timestamp":1783676213322,"version":"3.55.0"},"reference-count":36,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"John and Carol Walter Family Foundation"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2024,1,22]]},"DOI":"10.1080\/14656566.2024.2310073","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T09:24:45Z","timestamp":1706088285000},"page":"203-214","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Combination intravesical chemotherapy for non-muscle invasive bladder cancer (NMIBC) as first-line or rescue therapy: where do we stand now?"],"prefix":"10.1080","volume":"25","author":[{"given":"Mohamad","family":"Abou Chakra","sequence":"first","affiliation":[{"name":"Department of Urology, The University of Iowa Hospitals and Clinics, Iowa City, IA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh T.","family":"Packiam","sequence":"additional","affiliation":[{"name":"Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Jersey, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Duquesne","sequence":"additional","affiliation":[{"name":"Department of Urology, Cochin Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Peyromaure","sequence":"additional","affiliation":[{"name":"Department of Urology, Cochin Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"McElree","sequence":"additional","affiliation":[{"name":"Carver College of Medicine, University of Iowa, Iowa City, IA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Iowa Hospitals and Clinics, Iowa City, IA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.05.015"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.166446"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.6101"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.08.016"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.06.049"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2020.03.013"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2022.12.016"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.09.022"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-021-00457-1"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2023.2271396"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002957"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2008.11.019"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2022.10.030"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13088"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000688"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-150008"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.03.024"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-170126"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2013.01.009"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002740"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.0849"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.10.038"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000524098"},{"issue":"23","key":"e_1_3_5_27_1","first-page":"00229","article-title":"Sequential intravesical gemcitabine\/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy [published online ahead of print, 2023 Sep 8]","volume":"1078","author":"Yim K","year":"2023","unstructured":"Yim K, Melnick K, Mott SL, et al. Sequential intravesical gemcitabine\/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy [published online ahead of print, 2023 Sep 8]. Urol Oncol. 2023;S1078-1439(23):00229\u20136.","journal-title":"Urol Oncol"},{"issue":"23","key":"e_1_3_5_28_1","first-page":"00143","article-title":"Sequential intravesical gemcitabine and Docetaxel is an alternative to Bacillus Calmette-Gu\u00e9rin for the treatment of intermediate-risk non-muscle-invasive bladder cancer [published online ahead of print, 2023 Jul 18]","volume":"2588","author":"Tan WS","year":"2023","unstructured":"Tan WS, McElree IM, Davaro F, et al. Sequential intravesical gemcitabine and Docetaxel is an alternative to Bacillus Calmette-Gu\u00e9rin for the treatment of intermediate-risk non-muscle-invasive bladder cancer [published online ahead of print, 2023 Jul 18]. Eur Urol Oncol. 2023;S2588-9311(23):00143\u20138.","journal-title":"Eur Urol Oncol"},{"issue":"23","key":"e_1_3_5_29_1","first-page":"00228","article-title":"Sequential intravesical gemcitabine and docetaxel for treatment-na\u00efve and previously treated intermediate-risk nonmuscle invasive bladder cancer [published online ahead of print, 2023 Jul 11]","volume":"1078","author":"McElree IM","year":"2023","unstructured":"McElree IM, Orzel J, Stubbee R, et al. Sequential intravesical gemcitabine and docetaxel for treatment-na\u00efve and previously treated intermediate-risk nonmuscle invasive bladder cancer [published online ahead of print, 2023 Jul 11]. Urol Oncol. 2023;S1078-1439(23):00228\u20134.","journal-title":"Urol Oncol"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S341896"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003438"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2013.10.030"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000001065"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15209"},{"issue":"1","key":"e_1_3_5_35_1","first-page":"35","article-title":"Non-muscle-invasive bladder cancer management during BCG shortages: NYU case of the Month, February 2020","volume":"22","author":"Barlow LJ","year":"2020","unstructured":"Barlow LJ. Non-muscle-invasive bladder cancer management during BCG shortages: NYU case of the Month, February 2020. Rev Urol. 2020;22(1):35\u201336.","journal-title":"Rev Urol"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.02.012"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2023.04.005"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2020.10.039"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2024.2310073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:44:27Z","timestamp":1727189067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2024.2310073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,1,22]]}},"alternative-id":["10.1080\/14656566.2024.2310073"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2024.2310073","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}